These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 8084452)

  • 1. Direct measurement of reactive oxygen species in leukocytes during hemodialysis therapy.
    Okano K; Kimura K; Tanaka Y; Tsuchiya K; Akiba T; Nitta K
    Int J Clin Exp Med; 2015; 8(11):20959-64. PubMed ID: 26885025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of oxidative stress in chronic kidney disease: a review on current concepts and therapies.
    Verma S; Singh P; Khurana S; Ganguly NK; Kukreti R; Saso L; Rana DS; Taneja V; Bhargava V
    Kidney Res Clin Pract; 2021 Jun; 40(2):183-193. PubMed ID: 34078023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linking chronic kidney disease and Parkinson's disease: a literature review.
    Meléndez-Flores JD; Estrada-Bellmann I
    Metab Brain Dis; 2021 Jan; 36(1):1-12. PubMed ID: 32990929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local and Systemic Oxidative Stress in Balkan Endemic Nephropathy Is Not Associated with Xanthine Oxidase Activity.
    Veljković A; Hadži-Đokić J; Sokolović D; Čukuranović R; Čukuranović-Kokoris J; Bašić D; Đorđević B; Stojanović M; Šmelcerović A; Kocić G
    Oxid Med Cell Longev; 2020; 2020():8209727. PubMed ID: 32908640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative Stress in Hemodialysis Patients: A Review of the Literature.
    Liakopoulos V; Roumeliotis S; Gorny X; Dounousi E; Mertens PR
    Oxid Med Cell Longev; 2017; 2017():3081856. PubMed ID: 29138677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.
    March DS; Graham-Brown MP; Stover CM; Bishop NC; Burton JO
    Biomed Res Int; 2017; 2017():5765417. PubMed ID: 28194419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria: a new therapeutic target in chronic kidney disease.
    Granata S; Dalla Gassa A; Tomei P; Lupo A; Zaza G
    Nutr Metab (Lond); 2015; 12():49. PubMed ID: 26612997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the conformational state of hemoglobin in hemodialysed patients with chronic renal failure.
    Pieniazek A; Gwozdzinski K
    Oxid Med Cell Longev; 2015; 2015():783073. PubMed ID: 25866600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of neutrophil function during hemodialysis treatment in healthy dogs under anesthesia with sevoflurane.
    Shimamura S; Kimura K; Katayama M; Mashita T; Maeda K; Kobayashi S; Sato R; Yasuda J
    J Vet Med Sci; 2014 Nov; 76(11):1539-43. PubMed ID: 25141879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and nucleic acid oxidation in patients with chronic kidney disease.
    Sung CC; Hsu YC; Chen CC; Lin YF; Wu CC
    Oxid Med Cell Longev; 2013; 2013():301982. PubMed ID: 24058721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy.
    Krishnaswamy PR; Rao A; Murali W; Sudarshan Ballal H
    Indian J Clin Biochem; 2006 Sep; 21(2):173-6. PubMed ID: 23105639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reuse of polysulfone membrane on oxidative stress during hemodialysis.
    Ramakrishna P; Reddy EP; Suchitra MM; Bitla AR; Rao PV; Sivakumar V
    Indian J Nephrol; 2012 May; 22(3):200-5. PubMed ID: 23087556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of the regulation of leukocyte chemosensory migration by a vascular prosthetic biomaterial.
    Chang CC; Lieberman SM; Moghe PV
    J Mater Sci Mater Med; 2000 Jun; 11(6):337-44. PubMed ID: 15348014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis.
    Cristol JP; Canaud B; Rabesandratana H; Gaillard I; Serre A; Mion C
    Nephrol Dial Transplant; 1994; 9(4):389-94. PubMed ID: 8084452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subsets in dialyser eluates: a new parameter of bioincompatibility?
    Grooteman MP; Nube MJ; van Limbeek J; Schoorl M; van Houte AJ
    Nephrol Dial Transplant; 1996 Jun; 11(6):1073-8. PubMed ID: 8671971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients.
    Guz G; Glorieux GL; De Smet R; Waterloos MA; Vanholder RC; Dhondt AW
    Nephrol Dial Transplant; 2006 Oct; 21(10):2834-40. PubMed ID: 16762960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of leukocytes eluted from haemodialysers.
    Castiglione A; Pagliaro P; Romagnoni M; Beccari M; Cavaliere G; Veneroni G; Sorgato G
    Nephrol Dial Transplant; 1991; 6 Suppl 2():31-5. PubMed ID: 1866065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis.
    Tielemans CL; Delville JP; Husson CP; Madhoun P; Lambrechts AM; Goldman M; Vanherweghem JL
    Clin Nephrol; 1993 Mar; 39(3):158-65. PubMed ID: 8096446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation.
    Morena M; Delbosc S; Dupuy AM; Canaud B; Cristol JP
    Hemodial Int; 2005 Jan; 9(1):37-46. PubMed ID: 16191052
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.